Always great to see the humor on the board...Enjoyed your post very much...
The market is very soft right now... Exel may or may not get caught up in a tumble for Bio-Tech in general...My guess is that baring significant data release over the next 2-3 days, it does get caught up with everything else... Short term only, otherwise EXEL prospects are strong.
Couldn't agree more.... The crazies come out to move folks out of their position... Biggest risk now is how margined people are that are in the name. Every couple of day....those with stretched margins will get pressed until the mkt finds a bottom.
None of the shares have actually vested as of yet... April 1 is the initial vesting period. I do believe Mr. Mkt is going to have its way with all stocks today.
Simply that (9) Form 4's were reported after the close today, filled on January 4th
Stock grants that vest in four periods this year ,1/4 of the grant each period. I may have misrepresented the initial statement, These are new grants issued on vested schedule at a cost of $0 to the recipients. (again, I only looked a a couple, not all 9)
Example Stelios Papadopoulos Granted 15071 shares, vesting April 1, July 1 Sept 30 and Dec 30th. each period 1/4 of the shares vest.
The gang===BOD and C-Suite.
The gang is all in.... I didn't go thru all of them but doesn't look like anything acquired in the open mkt. Still looks like they wanted to exercise the options all at once
Just reviewed an article from August with Armune, Top end, repeat Top end estimates are for 10,000 per month screenings for prostate cancer. They have an internal lab where results are processed.(hint proprietary, good luck with that) $300/per screening (as reported in the article) total projected revenue prior to cost, 36M. So whatever the split with AEZS, it would be a joke as revenue generators go. Never mind that Armune has spent basically the whole of 2015 attempting to raise capital to go it alone, AEZS is a fallback position for them. Too Bad Armune is not listed, they would be a great short too. AEZS Management has been spinning this POS since the days of perifosine, Wash rinse repeat, New investors/gamblers get soaked all over again. Just goog perifosine..... That was a generic drug they thought they could turn into gold dust.
You are clearly a predator in the making, the spike in ISIS is clearly a short squeeze. It is headed down very soon. The daily is already there and the weekly is not far behind. If anyone plays ISIS. Now is not the time to go long. Not dismissing the antisense technology, simply saying the technicals set this up as a shorts play in the very near future.